CCS and leukemia: Li Y et al. (52) found CCS promoted the growth and migration of breast cancer cells by regulating ROS-mediated ERK1/2 activity.In leukemia, COX17 inhibition can increase the level of mitochondrial copper, thereby affecting methionine metabolism and DNA methylation, and reduce the activity of leukemia stem cells (53).